共 50 条
- [31] Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanismsNATURE MEDICINE, 2018, 24 (02) : 165 - +Bezzi, MarcoSeitzer, NinaIshikawa, TomokiReschke, MarkusChen, MingWang, GuocanMitchell, CaitlinNg, ChristopherKaton, JesseLunardi, AndreaSignoretti, SabinaClohessy, John G.Zhang, JiangwenPandolfi, Pier Paolo
- [32] Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal CancerFRONTIERS IN ONCOLOGY, 2021, 11Yang, MengxuanWei, ZhuangFeng, MeiZhu, YuanyuanChen, YongZhu, Di
- [33] Establishment of a catalog of somatic genetic alterations in Japanese cancer patients across multiple tumor typesCANCER SCIENCE, 2018, 109 : 1143 - 1143Serizawa, MasakuniNagashima, TakeshiOhshima, KeiichiHatakeyama, KeiichiOhnami, ShumpeiMaruyama, KojiSugino, TakashiMochizuki, TohruAkiyama, YasutoUrakami, KenichiKusuhara, MasatoshiYamaguchi, Ken
- [34] Detection of Microsatellite Instability Using a Large Next-generation Sequencing Panel across Diverse Tumor TypesJOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 964 - 964Pang, J.Mansukhani, M. M.Hsiao, S. J.
- [35] Diverse Drug Combinations with an Eed Inhibitor Confer Context-Specific Benefit across Multiple Tumor TypesBLOOD, 2021, 138Hsu, Jessie Hao-RuBorodovsky, SashaWang, YanjunMartin, Maryann SanShen, MinhuiWoods, HaleyRosen, AlanBagal, SharanRawlins, PhilipRobinson, JamesCode, ErinPrickett, LauraBloecher, Andrew
- [36] Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting functionNATURE COMMUNICATIONS, 2024, 15 (01)Andrade, Augusto FariaAnnett, AlvaKarimi, ElhamTopouza, Danai GeorgiaRezanejad, MortezaLiu, YitongMcNicholas, MichaelSantiago, Eduardo G. GonzalezLlivichuzhca-Loja, DhanaGehlhaar, ArneJessa, SelinDe Cola, AntonellaChandarana, BhavyaaRusso, CaterinaFaury, DamienDanieau, GeoffroyPuligandla, EvanWei, YuhongZeinieh, MicheleWu, QingHebert, StevenJuretic, NikoletaNakada, Emily M.Krug, BrianLarouche, ValerieWeil, Alexander G.Dudley, Roy W. R.Karamchandani, JasonAgnihotri, SameerQuail, Daniela F.Ellezam, BenjaminKonnikova, LizaWalsh, Logan A.Pathania, ManavKleinman, Claudia L.Jabado, Nada
- [37] Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer typesJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)Gandara, David R.Agarwal, NeerajGupta, ShilpaKlempner, Samuel J.Andrews, Miles C.Mahipal, AmitSubbiah, VivekEskander, Ramez N.Carbone, David P.Riess, Jonathan W.Sammons, SarahSnider, JeremyBouzit, LiliaCho-Phan, CherylPrice, MeganLi, GeraldQuintanilha, Julia C. F.Huang, Richard Sheng PoeRoss, Jeffrey S.Fabrizio, DavidOxnard, Geoffrey R.Graf, Ryon P.
- [38] Tumor Relapse Is Associated with an Innate Immune Resistant Phenotype across Tumor and Treatment Types Which Can Be Targeted with Rational Second Line TherapiesMOLECULAR THERAPY, 2013, 21 : S249 - S249Kottke, TimothyDonnelly, OliverBoisgerault, NicolasDiaz, RosaRommelfanger-Konkol, DianaPulido, JoseThompson, JillMukhopadhyay, DebabrataKnutson, KeithBehrens, MarshallKaspar, RogerCoffey, MattSelby, PeterHarrington, KevinMelcher, AlanPandha, HardevVile, Richard
- [39] Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of AdministrationTargeted Oncology, 2021, 16 : 773 - 787Siwen Hu-LieskovanFadi BraitehJuneko E. Grilley-OlsonXiao WangAlison ForgieVinicius BonatoIra A. JacobsJeffrey ChouMelissa L. Johnson
- [40] DISTINCT SYSTEMIC AND TUMOR MICROENVIRONMENT IMMUNE LANDSCAPES DISCRIMINATE ACROSS SELLAR TUMOR TYPES AND CONTROLS THROUGH A METHYLATION-BASED DECONVOLUTION METHODNEURO-ONCOLOGY, 2022, 24Herrgott, G.Asmaro, K.Thomas, B.Nelson, K.Cazacu, S.Hasselbach, L.Transou, A.deCarvalho, A.Mukherjee, A.Robin, A.Lee, IKalkanis, S.Rock, J.Rock, J.Noushmehr, H.Castro, A.